Point-of-Care Assays for Infliximab Therapeutic Drug Monitoring in Patients with IBD: Is Quicker Better?

被引：0
|
作者：
Levitte, Steven [1 ]
机构：
[1] Stanford Univ, Div Pediat Gastroenterol Hepatol & Nutr, 750 Welch Rd Ste 116, Palo Alto, CA 94304 USA
来源：
DIGESTIVE DISEASES AND SCIENCES | 2024年 / 69卷 / 01期
关键词：
D O I：
10.1007/s10620-023-08140-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：5 / 6
页数：2
相关论文
共 50 条
  • [31] Streamlining point-of-care assays
    不详
    NATURE BIOMEDICAL ENGINEERING, 2023, 7 (12) : 1531 - 1532
  • [32] Streamlining point-of-care assays
    Nature Biomedical Engineering, 2023, 7 : 1531 - 1532
  • [33] Point-of-care and utility in clinical trials: making quicker decisions to transform patient care and drug development
    Fischer, Saloumeh K.
    BIOANALYSIS, 2020, 12 (15) : 1039 - 1041
  • [34] Point-of-care thrombelastography assays for coagulopathy in trauma patients
    Craft, R.
    Carroll, R.
    Langdon, R.
    Clanton, C.
    Snider, C.
    Lawson, C.
    Enderson, B.
    Kurek, S.
    TRANSFUSION, 2008, 48 (02) : 81A - 81A
  • [35] Therapeutic drug monitoring with infliximab
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2022, 4 (02): : E88 - E88
  • [36] Reliability evaluation of four different assays for therapeutic drug monitoring of infliximab levels
    Perez, Irene
    Fernandez, Lidia
    Sanchez-Ramon, Silvia
    Alba, Cristina
    Zatarain, Ana
    Canas, Mercedes
    Lopez, Olga N.
    Olivares, David
    Rey, Enrique
    Taxonera, Carlos
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2018, 11
  • [37] INFLIXIMAB THERAPEUTIC DRUG MONITORING IN IBD VIRTUAL BIOLOGICS CLINIC LEADS TO DURABLE RESULTS
    Selinger, Christian
    Lenti, Marco
    Clark, Tanya
    Rafferty, Helen
    Gracie, David
    Ford, Alex
    O'Connor, Anthony
    Ahmad, Tariq
    Hamlin, John
    Sagar, Rebecca
    GUT, 2018, 67 : A94 - A94
  • [38] The impact of infliximab therapeutic drug monitoring on decisions made in a virtual biologics clinic for IBD
    Selinger, C.
    Lenti, M.
    Clark, T.
    Rafferty, H.
    O'Connor, A.
    Ahmad, T.
    Hamlin, J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S411 - S412
  • [39] Prospective Therapeutic Drug Monitoring to Optimizing Infliximab (IFX) Maintenance Therapy in Patients With Inflammatory Bowel Disease (IBD)
    Vaughn, Byron P.
    Martinez-Vazquez, Manuel
    Patwardhan, Vilas
    Moss, Alan C.
    Sandborn, William J.
    Cheifetz, Adam S.
    GASTROENTEROLOGY, 2014, 146 (05) : S54 - S54
  • [40] Outcomes of IBD patients treated with infliximab: The impact of therapeutic drug monitoring in real-life clinical practice
    Kamperidis, N.
    Middleton, P.
    Tyrrell, T.
    Stasinos, I.
    Arebi, N.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S394 - S394
12345